REPORT ID 1803

Global Migraine Drugs Market Professional Survey Report 2017

Publish Date
06-Dec-17
Pages
116
Format
Electronic (PDF)

This report studies Migraine Drugs in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
    AstraZeneca Plc.
    Allergan Plc.
    Pfizer, Inc.
    Teva Pharmaceutical Industries Ltd.
    GlaxoSmithKline Plc
    Eli Lilly & Co.
    Novartis AG
    Merck & Co., Inc.
    Valeant Pharmaceutical International, Inc.
    Janssen Pharmaceutical Company (Johnson & Johnson)
    Endo Pharmaceuticals Inc.
    Zosano Pharma Corporation
    Alder BioPharmaceuticals Inc.
    Avanir Pharmaceuticals, Inc.
    Eisai Co., Ltd.

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Oral
    Injectable
    Others

By Application, the market can be split into
    Retail Pharmacies
    Hospital Pharmacies
    Others

By Regions, this report covers (we can add the regions/countries as you want)
    North America
    China
    Europe
    Southeast Asia
    Japan
    India

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Global Migraine Drugs Market Professional Survey Report 2017
1 Industry Overview of Migraine Drugs
    1.1 Definition and Specifications of Migraine Drugs
        1.1.1 Definition of Migraine Drugs
        1.1.2 Specifications of Migraine Drugs
    1.2 Classification of Migraine Drugs
        1.2.1 Oral
        1.2.2 Injectable
        1.2.3 Others
    1.3 Applications of Migraine Drugs
        1.3.1 Retail Pharmacies
        1.3.2 Hospital Pharmacies
        1.3.3 Others
    1.4 Market Segment by Regions
        1.4.1 North America
        1.4.2 China
        1.4.3 Europe
        1.4.4 Southeast Asia
        1.4.5 Japan
        1.4.6 India

2 Manufacturing Cost Structure Analysis of Migraine Drugs
    2.1 Raw Material and Suppliers
    2.2 Manufacturing Cost Structure Analysis of Migraine Drugs
    2.3 Manufacturing Process Analysis of Migraine Drugs
    2.4 Industry Chain Structure of Migraine Drugs

3 Technical Data and Manufacturing Plants Analysis of Migraine Drugs
    3.1 Capacity and Commercial Production Date of Global Migraine Drugs Major Manufacturers in 2016
    3.2 Manufacturing Plants Distribution of Global Migraine Drugs Major Manufacturers in 2016
    3.3 R&D Status and Technology Source of Global Migraine Drugs Major Manufacturers in 2016
    3.4 Raw Materials Sources Analysis of Global Migraine Drugs Major Manufacturers in 2016

4 Global Migraine Drugs Overall Market Overview
    4.1 2012-2017E Overall Market Analysis
    4.2 Capacity Analysis
        4.2.1 2012-2017E Global Migraine Drugs Capacity and Growth Rate Analysis
        4.2.2 2016 Migraine Drugs Capacity Analysis (Company Segment)
    4.3 Sales Analysis
        4.3.1 2012-2017E Global Migraine Drugs Sales and Growth Rate Analysis
        4.3.2 2016 Migraine Drugs Sales Analysis (Company Segment)
    4.4 Sales Price Analysis
        4.4.1 2012-2017E Global Migraine Drugs Sales Price
        4.4.2 2016 Migraine Drugs Sales Price Analysis (Company Segment)

5 Migraine Drugs Regional Market Analysis
    5.1 North America Migraine Drugs Market Analysis
        5.1.1 North America Migraine Drugs Market Overview
        5.1.2 North America 2012-2017E Migraine Drugs Local Supply, Import, Export, Local Consumption Analysis
        5.1.3 North America 2012-2017E Migraine Drugs Sales Price Analysis
        5.1.4 North America 2016 Migraine Drugs Market Share Analysis
    5.2 China Migraine Drugs Market Analysis
        5.2.1 China Migraine Drugs Market Overview
        5.2.2 China 2012-2017E Migraine Drugs Local Supply, Import, Export, Local Consumption Analysis
        5.2.3 China 2012-2017E Migraine Drugs Sales Price Analysis
        5.2.4 China 2016 Migraine Drugs Market Share Analysis
    5.3 Europe Migraine Drugs Market Analysis
        5.3.1 Europe Migraine Drugs Market Overview
        5.3.2 Europe 2012-2017E Migraine Drugs Local Supply, Import, Export, Local Consumption Analysis
        5.3.3 Europe 2012-2017E Migraine Drugs Sales Price Analysis
        5.3.4 Europe 2016 Migraine Drugs Market Share Analysis
    5.4 Southeast Asia Migraine Drugs Market Analysis
        5.4.1 Southeast Asia Migraine Drugs Market Overview
        5.4.2 Southeast Asia 2012-2017E Migraine Drugs Local Supply, Import, Export, Local Consumption Analysis
        5.4.3 Southeast Asia 2012-2017E Migraine Drugs Sales Price Analysis
        5.4.4 Southeast Asia 2016 Migraine Drugs Market Share Analysis
    5.5 Japan Migraine Drugs Market Analysis
        5.5.1 Japan Migraine Drugs Market Overview
        5.5.2 Japan 2012-2017E Migraine Drugs Local Supply, Import, Export, Local Consumption Analysis
        5.5.3 Japan 2012-2017E Migraine Drugs Sales Price Analysis
        5.5.4 Japan 2016 Migraine Drugs Market Share Analysis
    5.6 India Migraine Drugs Market Analysis
        5.6.1 India Migraine Drugs Market Overview
        5.6.2 India 2012-2017E Migraine Drugs Local Supply, Import, Export, Local Consumption Analysis
        5.6.3 India 2012-2017E Migraine Drugs Sales Price Analysis
        5.6.4 India 2016 Migraine Drugs Market Share Analysis

6 Global 2012-2017E Migraine Drugs Segment Market Analysis (by Type)
    6.1 Global 2012-2017E Migraine Drugs Sales by Type
    6.2 Different Types of Migraine Drugs Product Interview Price Analysis
    6.3 Different Types of Migraine Drugs Product Driving Factors Analysis
        6.3.1 Oral of Migraine Drugs Growth Driving Factor Analysis
        6.3.2 Injectable of Migraine Drugs Growth Driving Factor Analysis
        6.3.3 Others of Migraine Drugs Growth Driving Factor Analysis

7 Global 2012-2017E Migraine Drugs Segment Market Analysis (by Application)
    7.1 Global 2012-2017E Migraine Drugs Consumption by Application
    7.2 Different Application of Migraine Drugs Product Interview Price Analysis
    7.3 Different Application of Migraine Drugs Product Driving Factors Analysis
        7.3.1 Retail Pharmacies of Migraine Drugs Growth Driving Factor Analysis
        7.3.2 Hospital Pharmacies of Migraine Drugs Growth Driving Factor Analysis
        7.3.3 Others of Migraine Drugs Growth Driving Factor Analysis

8 Major Manufacturers Analysis of Migraine Drugs
    8.1 AstraZeneca Plc.
        8.1.1 Company Profile
        8.1.2 Product Picture and Specifications
            8.1.2.1 Product A
            8.1.2.2 Product B
        8.1.3 AstraZeneca Plc. 2016 Migraine Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.1.4 AstraZeneca Plc. 2016 Migraine Drugs Business Region Distribution Analysis
    8.2 Allergan Plc.
        8.2.1 Company Profile
        8.2.2 Product Picture and Specifications
            8.2.2.1 Product A
            8.2.2.2 Product B
        8.2.3 Allergan Plc. 2016 Migraine Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.2.4 Allergan Plc. 2016 Migraine Drugs Business Region Distribution Analysis
    8.3 Pfizer, Inc.
        8.3.1 Company Profile
        8.3.2 Product Picture and Specifications
            8.3.2.1 Product A
            8.3.2.2 Product B
        8.3.3 Pfizer, Inc. 2016 Migraine Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.3.4 Pfizer, Inc. 2016 Migraine Drugs Business Region Distribution Analysis
    8.4 Teva Pharmaceutical Industries Ltd.
        8.4.1 Company Profile
        8.4.2 Product Picture and Specifications
            8.4.2.1 Product A
            8.4.2.2 Product B
        8.4.3 Teva Pharmaceutical Industries Ltd. 2016 Migraine Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.4.4 Teva Pharmaceutical Industries Ltd. 2016 Migraine Drugs Business Region Distribution Analysis
    8.5 GlaxoSmithKline Plc
        8.5.1 Company Profile
        8.5.2 Product Picture and Specifications
            8.5.2.1 Product A
            8.5.2.2 Product B
        8.5.3 GlaxoSmithKline Plc 2016 Migraine Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.5.4 GlaxoSmithKline Plc 2016 Migraine Drugs Business Region Distribution Analysis
    8.6 Eli Lilly & Co.
        8.6.1 Company Profile
        8.6.2 Product Picture and Specifications
            8.6.2.1 Product A
            8.6.2.2 Product B
        8.6.3 Eli Lilly & Co. 2016 Migraine Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.6.4 Eli Lilly & Co. 2016 Migraine Drugs Business Region Distribution Analysis
    8.7 Novartis AG
        8.7.1 Company Profile
        8.7.2 Product Picture and Specifications
            8.7.2.1 Product A
            8.7.2.2 Product B
        8.7.3 Novartis AG 2016 Migraine Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.7.4 Novartis AG 2016 Migraine Drugs Business Region Distribution Analysis
    8.8 Merck & Co., Inc.
        8.8.1 Company Profile
        8.8.2 Product Picture and Specifications
            8.8.2.1 Product A
            8.8.2.2 Product B
        8.8.3 Merck & Co., Inc. 2016 Migraine Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.8.4 Merck & Co., Inc. 2016 Migraine Drugs Business Region Distribution Analysis
    8.9 Valeant Pharmaceutical International, Inc.
        8.9.1 Company Profile
        8.9.2 Product Picture and Specifications
            8.9.2.1 Product A
            8.9.2.2 Product B
        8.9.3 Valeant Pharmaceutical International, Inc. 2016 Migraine Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.9.4 Valeant Pharmaceutical International, Inc. 2016 Migraine Drugs Business Region Distribution Analysis
    8.10 Janssen Pharmaceutical Company (Johnson & Johnson)
        8.10.1 Company Profile
        8.10.2 Product Picture and Specifications
            8.10.2.1 Product A
            8.10.2.2 Product B
        8.10.3 Janssen Pharmaceutical Company (Johnson & Johnson) 2016 Migraine Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.10.4 Janssen Pharmaceutical Company (Johnson & Johnson) 2016 Migraine Drugs Business Region Distribution Analysis
    8.11 Endo Pharmaceuticals Inc.
    8.12 Zosano Pharma Corporation
    8.13 Alder BioPharmaceuticals Inc.
    8.14 Avanir Pharmaceuticals, Inc.
    8.15 Eisai Co., Ltd.

9 Development Trend of Analysis of Migraine Drugs Market
    9.1 Global Migraine Drugs Market Trend Analysis
        9.1.1 Global 2017-2022 Migraine Drugs Market Size (Volume and Value) Forecast
        9.1.2 Global 2017-2022 Migraine Drugs Sales Price Forecast
    9.2 Migraine Drugs Regional Market Trend
        9.2.1 North America 2017-2022 Migraine Drugs Consumption Forecast
        9.2.2 China 2017-2022 Migraine Drugs Consumption Forecast
        9.2.3 Europe 2017-2022 Migraine Drugs Consumption Forecast
        9.2.4 Southeast Asia 2017-2022 Migraine Drugs Consumption Forecast
        9.2.5 Japan 2017-2022 Migraine Drugs Consumption Forecast
        9.2.6 India 2017-2022 Migraine Drugs Consumption Forecast
    9.3 Migraine Drugs Market Trend (Product Type)
    9.4 Migraine Drugs Market Trend (Application)

10 Migraine Drugs Marketing Type Analysis
    10.1 Migraine Drugs Regional Marketing Type Analysis
    10.2 Migraine Drugs International Trade Type Analysis
    10.3 Traders or Distributors with Contact Information of Migraine Drugs by Region
    10.4 Migraine Drugs Supply Chain Analysis

11 Consumers Analysis of Migraine Drugs
    11.1 Consumer 1 Analysis
    11.2 Consumer 2 Analysis
    11.3 Consumer 3 Analysis
    11.4 Consumer 4 Analysis

12 Conclusion of the Global Migraine Drugs Market Professional Survey Report 2017
    Methodology
    Analyst Introduction
    Data Source